Goyal Akash, Yu Francois T H, Tenwalde Mathea G, Chen Xucai, Althouse Andrew, Villanueva Flordeliza S, Pacella John J
Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Clinical Biostatistics Core, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Ultrasound Med Biol. 2017 Jul;43(7):1391-1400. doi: 10.1016/j.ultrasmedbio.2017.02.013. Epub 2017 Apr 7.
We have previously reported that long-tone-burst, high-mechanical-index ultrasound (US) and microbubble (MB) therapy can restore perfusion in both in vitro and in vivo models of microvascular obstruction (MVO). Addition of MBs to US has been found to potentiate the efficacy of thrombolytics on large venous thrombi; however, the optimal US parameters for achieving microvascular reperfusion of MVO caused by microthrombi, when combined with tissue plasminogen activator (tPA), are unknown. We sought to elucidate the specific effects of US, with and without tPA, for effective reperfusion of MVO in an in vitro model using both venous and arterial microthrombi. Venous- and arterial-type microthrombi were infused onto a mesh with 40-μm pores to simulate MVO. Pulsed US (1 MHz) was delivered with inertial cavitation (IC) (1.0 MPa, 1000 cycles, 0.33 Hz) and stable cavitation (SC) US (0.23 MPa, 20% duty cycle, 0.33 Hz) regimes while MB suspension (2 × 10 MBs/mL) was infused. The efficacy of sonoreperfusion with these parameters was tested with and without tPA. Sonoreperfusion efficacy was significantly greater for IC + tPA compared with tPA alone, IC, SC and SC + tPA, suggesting lytic synergism between tPA and US for both venous- and arterial-type microthrombi. In contrast to our previous in vitro studies using 1.5 MPa at 5000 US cycles without tPA, the IC regime employed herein used 90% less US energy. These findings suggest an IC regime can be used with tPA synergistically to achieve a high degree of fibrinolysis for both thrombus types.
我们之前曾报道,长脉冲串、高机械指数超声(US)与微泡(MB)联合治疗可在体外和体内微血管阻塞(MVO)模型中恢复灌注。已发现向超声中添加微泡可增强溶栓剂对大静脉血栓的疗效;然而,当与组织纤溶酶原激活剂(tPA)联合使用时,实现由微血栓引起的MVO微血管再灌注的最佳超声参数尚不清楚。我们试图阐明超声(无论有无tPA)在使用静脉和动脉微血栓的体外模型中对MVO有效再灌注的具体作用。将静脉型和动脉型微血栓注入具有40μm孔隙的网片上以模拟MVO。在注入微泡悬浮液(2×10个微泡/mL)的同时,采用惯性空化(IC)(1.0MPa,1000个周期,0.33Hz)和稳定空化(SC)超声(0.23MPa,20%占空比,0.33Hz)模式施加脉冲超声(1MHz)。在有和没有tPA的情况下测试了这些参数的超声再灌注疗效。与单独使用tPA、IC、SC和SC + tPA相比,IC + tPA的超声再灌注疗效显著更高,这表明tPA与超声在静脉型和动脉型微血栓方面具有溶栓协同作用。与我们之前在不使用tPA的情况下以5000个超声周期使用1.5MPa的体外研究相比,本文采用的IC模式使用的超声能量减少了90%。这些发现表明,IC模式可与tPA协同使用,以实现两种血栓类型的高度纤维蛋白溶解。